An Epigenetic Mechanism Underlying Doxorubicin Induced EMT in the Human BGC-823 Gastric Cancer Cell |
Han, Rong-Fei
(Department of Immunology, Wuhan University School of Basic Medical Science)
Ji, Xiang (Department of Immunology, Wuhan University School of Basic Medical Science) Dong, Xing-Gao (Department of Immunology, Hubei University for Nationalities) Xiao, Rui-Jing (Department of Immunology, Wuhan University School of Basic Medical Science) Liu, Yan-Ping (Department of Neurology, Huashan Hospital, Fudan University) Xiong, Jie (Department of Immunology, Wuhan University School of Basic Medical Science) Zhang, Qiu-Ping (Department of Immunology, Wuhan University School of Basic Medical Science) |
1 | Zhu QC, Gao RY, Wu W, Qin HL (2013). Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer. Asian Pac J Cancer Prev, 14, 2689-98. 과학기술학회마을 DOI ScienceOn |
2 | Sharma SV, Lee DY, Li B, et al (2010). A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell, 141, 69-80. DOI ScienceOn |
3 | Mak AB, Nixon AM, Kittanakom S, et al (2012). Regulation of CD133 by HDAC6 promotes beta-catenin signaling to suppress cancer cell differentiation. Cell Rep, 2, 951-63. DOI ScienceOn |
4 | Sarkar FH, Li Y, Wang Z, Kong D (2009). Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chir, 64, 489-500. |
5 | Scheel C, Eaton EN, Li SH, et al (2011). Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell, 145, 926-40. DOI ScienceOn |
6 | Shi D, Pop MS, Kulikov R, et al (2009). CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. Proc Natl Acad Sci USA, 106, 16275-80. DOI ScienceOn |
7 | Singh A, Settleman J (2010). EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene, 29, 4741-51. DOI ScienceOn |
8 | Suva ML, Riggi N, Bernstein BE (2013). Epigenetic reprogramming in cancer. Science, 339, 1567-70. DOI ScienceOn |
9 | Wolf D, Rodova M, Miska EA, Calvet JP, Kouzarides T (2002). Acetylation of beta-catenin by CREB-binding protein (CBP). J Biol Chem, 277, 25562-7. DOI ScienceOn |
10 | Yang M, Waterman ML, Brachmann RK (2008). hADA2a and hADA3 are required for acetylation, transcriptional activity and proliferative effects of beta-catenin. Cancer Biol Ther, 7, 120-8. DOI |
11 | Zahreddine H, Borden KL (2013). Mechanisms and insights into drug resistance in cancer. Front Pharmacol, 4, 28. |
12 | Chaffer CL, Brueckmann I, Scheel C, et al (2011). Normal and neoplastic nonstem cells can spontaneously convert to a stemlike state. Proc Natl Acad Sci USA, 108, 7950-5. DOI ScienceOn |
13 | Garraway LA, Janne PA (2012). Circumventing cancer drug resistance in the era of personalized medicine. Cancer Discov, 2, 214-26. DOI |
14 | Han R, Xiong J, Xiao R, et al (2013). Activation of beta-catenin signaling is critical for doxorubicin-induced epithelialmesenchymal transition in BGC-823 gastric cancer cell line. Tumour Biol, 34, 277-84. DOI ScienceOn |
15 | Haslehurst AM, Koti M, et al (2012). EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer, 12, 91. DOI ScienceOn |
16 | Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG (2013). Cancer drug resistance: an evolving paradigm. Nat Rev Cancer, 13, 714-26. DOI ScienceOn |
17 | Iyer NG, Ozdag H, Caldas C (2004). p300/CBP and cancer. Oncogene, 23, 4225-31. DOI ScienceOn |
18 | Kim MC, Cui FJ, Kim Y (2013). Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells. Asian Pac J Cancer Prev, 14, 3625-30. 과학기술학회마을 DOI ScienceOn |
19 | Li Y, Zhang X, Polakiewicz RD, Yao TP, Comb MJ (2008). HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization. J Biol Chem, 283, 12686-90. DOI |
20 | Yang J, Weinberg RA (2008). Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell, 14, 818-29. DOI ScienceOn |